Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Sermonizer VS Whinersssssssssssssssssssss

<< Previous

Bullboard Posts

Next >>

Comment by scarlet1967on Feb 02, 2021 5:01pm

105 Views

Post# 32452864

RE:Sermonizer VS Whinersssssssssssssssssssss

And what if oncology hit the brick wall, although no value has been ascribed to the program as mentioned earlier the stock hasn't had any problem reacting to bad news therefore I would be more comparable if the SP was much higher during that trial.Some might don't mind loosing money or not making money during a bull market well I absolutely DO.

palinc2000 wrote: but at least we now know that if phase 3 trials are successful in Nash and oncology the SP will go to the moon,
I feel much better now,,,,

Disclosure
I am long this stock and have no relation whatsoever with anyone working at TH past or present

<< Previous

Bullboard Posts

Next >>

@ the Bell: TSX advances to start off Christmas trading week